PubMed:26253900 / 0-153
Annnotations
PubTator4TogoVar
| Id | Subject | Object | Predicate | Lexical cue | proteinmutation |
|---|---|---|---|---|---|
| 26253900_0 | 0-6 | ProteinMutation | denotes | G2019S | rs34637584 |
c_corpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 7-12 | PR:Q5S006 | denotes | LRRK2 |
| T2 | 7-12 | PR:000003033 | denotes | LRRK2 |
| T3 | 7-12 | PR:Q5S007 | denotes | LRRK2 |
| T4 | 17-22 | GO:0007568 | denotes | aging |
| T5 | 30-44 | D004198 | denotes | susceptibility |
| T6 | 30-44 | D004198 | denotes | susceptibility |
| T8 | 48-58 | GO:0000502 | denotes | proteasome |
| T7 | 48-58 | GO:0004299 | denotes | proteasome |
| T9 | 48-68 | D061988 | denotes | proteasome inhibitor |
| T10 | 48-68 | D061988 | denotes | proteasome inhibitor |
| T11 | 48-68 | CHEBI:52726 | denotes | proteasome inhibitor |
| T13 | 108-127 | UBERON:0027239 | denotes | dopaminergic system |
| T15 | 133-140 | 6308 | denotes | leucine |
| T16 | 133-140 | SO:0001437 | denotes | leucine |
| T14 | 133-140 | CHEBI:15603 | denotes | leucine |
| T17 | 133-140 | D007930 | denotes | leucine |
| T18 | 133-140 | CHEBI:25017 | denotes | leucine |
| T19 | 133-140 | D007930 | denotes | leucine |
| T20 | 146-152 | SO:0001068 | denotes | repeat |
UseCases_ArguminSci_Discourse
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-6 | REPLACED | denotes | G2019S |
| T2 | 7-12 | Token_Label.OUTSIDE | denotes | LRRK2 |
| T3 | 13-128 | DRI_Background | denotes | and aging confer susceptibility to proteasome inhibitor-induced neurotoxicity in nigrostriatal dopaminergic system. |